Science / Turmeric

Shoba et al. · 1998 — Curcumin Study — Professional

High-Potency Turmeric Extract · NPN 80143038. Product facts and study findings are identified separately.

Shoba et al. · 1998 · Ingredient Evidence

Evidence Type: Human pharmacokinetic study; animal experiments reported separately.
Studied Material / Formulation: Curcumin alone or with piperine; no DR.MORGAN material.
Population: 8 healthy volunteers completed the human component.
Dose: Single 2 g curcumin dose, with or without 20 mg piperine.
Duration: Acute sampling through 6 hours.
Main Findings: Piperine increased measured serum exposure under these experimental conditions.
Limitations: Small sample; acute exposure rather than clinical benefit; animal results are not human outcomes.
Product Relevance: Absorption context only. Piperine is not listed in this product; no absorption multiplier is attributed to it.
DR.MORGAN finished product studied: NO

This study was not conducted on the finished DR.MORGAN product.

Source review: Original publication reviewed; formulation-specific interpretation. DOI 10.1055/s-2006-957450. PMID 9619120.

Licensed product information